poisar

Stocks · News reference

8-K filing — Liminatus Pharma, Inc. (LIMNW)

SEC EDGARJul 24, 2026, 8:51 PMSEC EDGAR

Filed: 2026-07-24 AccNo: 0001104659-26-086674 Size: 244 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Jul 24, 2026, 8:51 PM
Checked
Jul 24, 2026, 8:51 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 18, 2026, 8:06 PMSEC EDGAR

    8-K filing — Liminatus Pharma, Inc. (LIMNW)

    Filed: 2026-08-18 AccNo: 0001104659-26-098335 Size: 285 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar